After patient deaths, InVivo slashes staff and ousts science chief
August 29, 2017 at 12:14 PM EDT
The restructuring follows a setback in the Cambridge biotech's effort to win approval for a spinal cord injury treatment.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.